Liver Tests, Cardiovascular Outcomes and Effects of Empagliflozin in Patients with Heart Failure and Preserved Ejection Fraction: The Emperor-Preserved Trial
AuthID
P-00Y-R1E
P-00Y-R1E
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service